{"filing":{"accession_number":"0001213900-26-072722","cik":"0001468492","ticker":"HSCSW","company_name":"HeartSciences Inc.","form":"8-K","filing_date":"2026-06-26","report_date":null,"primary_document":"ea0296127-8k_heartsci.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1468492/000121390026072722/ea0296127-8k_heartsci.htm"},"events":[{"id":14366,"run_id":12788,"accession_number":"0001213900-26-072722","anchor_item_number":"5.02","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"HeartSciences Inc. entered into an Agreement and Plan of Merger on June 23, 2026, whereby the company will acquire Fortitude Mining Holdings, Inc. through a merger transaction.","company_name":"HeartSciences Inc.","ticker":"HSCSW","filing_date":"2026-06-26","form":"8-K","submitted_at":null,"items":[{"id":11763,"accession_number":"0001213900-26-072722","item_number":"5.02","item_title":"Departure of Directors or Certain","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"The filing discloses entry into an Agreement and Plan of Merger on June 23, 2026, whereby HeartSciences will acquire Fortitude Mining Holdings, Inc. through a merger transaction. While Item 5.02 nominally covers executive compensation and appointments, the dominant disclosed event is the material acquisition activity—the Merger Agreement itself—which is the triggering event for all subsequent compensation amendments and officer appointments. The M\u0026A transaction is the material event that a reasonable investor would prioritize.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-26T21:23:43.175755+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":14367,"run_id":12788,"accession_number":"0001213900-26-072722","anchor_item_number":"3.02","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.75,"summary":"HeartSciences issued unregistered equity securities as compensatory awards to officers or directors, with the disclosure incorporating Item 5.02 by reference and relying on officer/director representations regarding the exemption.","company_name":"HeartSciences Inc.","ticker":"HSCSW","filing_date":"2026-06-26","form":"8-K","submitted_at":null,"items":[{"id":11762,"accession_number":"0001213900-26-072722","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"Item 3.02 discloses an unregistered issuance of equity securities (an \"Equity Award\"), but the disclosure explicitly incorporates Item 5.02 by reference and relies on officer/director representations regarding the exemption. The substance of the disclosure centers on a compensatory equity award to officers or directors rather than a capital-raising transaction, making this an executive compensation event. The materiality reflects the issuance of equity to named executives.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-26T21:23:43.175755+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":11762,"accession_number":"0001213900-26-072722","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"Item 3.02 discloses an unregistered issuance of equity securities (an \"Equity Award\"), but the disclosure explicitly incorporates Item 5.02 by reference and relies on officer/director representations regarding the exemption. The substance of the disclosure centers on a compensatory equity award to officers or directors rather than a capital-raising transaction, making this an executive compensation event. The materiality reflects the issuance of equity to named executives.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-26T21:23:43.175755+00:00","company_name":"HeartSciences Inc.","ticker":"HSCSW","filing_date":"2026-06-26"},{"id":11763,"accession_number":"0001213900-26-072722","item_number":"5.02","item_title":"Departure of Directors or Certain","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"The filing discloses entry into an Agreement and Plan of Merger on June 23, 2026, whereby HeartSciences will acquire Fortitude Mining Holdings, Inc. through a merger transaction. While Item 5.02 nominally covers executive compensation and appointments, the dominant disclosed event is the material acquisition activity—the Merger Agreement itself—which is the triggering event for all subsequent compensation amendments and officer appointments. The M\u0026A transaction is the material event that a reasonable investor would prioritize.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-26T21:23:43.175755+00:00","company_name":"HeartSciences Inc.","ticker":"HSCSW","filing_date":"2026-06-26"}]}